Relations of magnesium intake to cognitive impairment and dementia among participants in the Women’s Health Initiative Memory Study: a prospective cohort study
BMJ Open http://dx.doi.org/10.1136/bmjopen-2019-030052
Kenneth Lo1,2, Qing Liu2, Tracy Madsen2,3, Steve Rapp4, Jiu-Chiuan Chen5, Marian Neuhouser6, Aladdin Shadyab7, Lubna Pal8, Xiaochen Lin2, Sally Shumaker4, JoAnn Manson9, Ying-Qing Feng1, Simin Liu2,10
Items in both categories Cognitive and Magnesium are listed here:
- Magnesium can reduce neuroinflammation and cognitive decline – Sept 2024
- 800 mg of Magnesium early in 3rd trimester significantly increased brain activity in preterm infants – RCT May 2024
- Alzheimer’s patients have less Magnesium – meta-analysis Jan 2022
- Less cognitive decline in women consuming more Magnesium (and vitamins) – Nov 2019
- IQ 4 points lower in male children if fluoridated water while pregnant (perhaps Magnesium) – Aug 2019
- Senior cognition poor if low vitamin D and low Magnesium intake – June 2019
- Magnesium may be an important way to treat brain trauma
- Dementia less likely with increased levels of Magnesium etc.
Far more studies showing association of Omega-3 with cognition
 Download the PDF from VitaminDWiki
Many vitamins increase with increase in Magnesium
Objective To examine the associations of dietary and supplemental magnesium (Mg) as assessed by a semi-quantitative food frequency questionnaire with cognitive outcomes among ageing women.
Design This work conducts a prospective cohort study of participants enrolled in the Women’s Health Initiative Memory Study (WHIMS), which was subsequently extended and named WHIMS-Epidemiology of Cognitive Health.
Setting Forty clinical centres in the USA.
Participants Postmenopausal women aged 65–79 years without dementia on enrollment.
Main outcome measures Physician-adjudicated mild cognitive impairment (MCI) and/or probable dementia (PD).
Results Participants were excluded (n=1006) if they had extreme values of dietary energy intake, had missing or extreme body mass index values, with prevalent MCI/PD at baseline, received only one cognitive assessment or had been followed up for <1 year. During >20 years of follow-up, 765 (11.8%) out of 6473 participants developed MCI/PD. For MCI/PD and MCI, the risks tended to be lower among participants in quintiles Q2–Q5 of Mg consumption compared with those in the lowest quintile. Participants in Q3 had a significantly lower risk of MCI/PD (HR 0.69, 95% CI 0.53 to 0.91) and MCI (HR 0.63, 95% CI 0.45 to 0.87) after multivariate adjustments. No significant association was observed between total Mg intake and PD. The association between total Mg intake, MCI/PD and MCI was non-linear as suggested by the likelihood test.
Conclusions Total Mg intake between the estimated average requirement and the recommended dietary allowances may associate with a lower risk of MCI/PD and MCI.
Trial registration number NCT00685009.
Strengths and limitations of this study
- A large prospective cohort with long follow-up and careful adjudication of mild cognitive impairment/probable dementia events to ensure a high quality of outcome assessment.
- Lacking information on serum magnesium levels in the studied population.
- The cohort included only postmenopausal women, and the findings may not be generalisable to elderly men.
2525 visitors, last modified 20 Nov, 2019, |
ID | Name | Uploaded | Size | Downloads | |
---|---|---|---|---|---|
13013 | Variables which correlate with Mg.jpg | admin 20 Nov, 2019 | 121.90 Kb | 493 | |
13012 | Mg cogntive decline.pdf | admin 20 Nov, 2019 | 332.94 Kb | 453 |